BIOEMTECH’s mission and passion is accelerating preclinical research of promising drugs, towards clinical translation, through precisely targeted services and products. BIOEMTECH leverages its own boutique laboratories to drive innovation and ensure quality, for evaluating new compounds in all stages of preclinical testing, GLP toxicology and alpha emitters therapy schemes. It has developed the eyesTM desktop cameras for real-time in vivo imaging of SPECT and PET radionuclides and dyes. The eyesTM offer unmatched excellence in the challenging in vivo imaging of alpha emitters (212Pb & 225Ac) for oncological models, in short scanning times and clinically relevant doses. Both in BIOEMTECH’s services and products, fast screening applications are a core company value towards accelerating drug development. Finally, BIOEMTECH is active as an preclinical partner in several projects including H2020, FET, ERA, ITN and more.
The company was funded by the Action of the Competitiveness Programme (NSRF 2021-2027) "Green Productive Investment of SMEs" of the "Green Transition SMEs" Action Cluster. The Action aims at the exploitation and development of modern technologies by SMEs, the upgrading of their products/services and activities in general.
Company Details
- Employees
- 43
- Founded
- -
- Address
- 271 Kleisthenous, Gerakas,attica 153 44,greece
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bioemtech.com
- Keywords
- Small animal imaging, Dedicated imaging systems, Radiolabeling of biomolecules and nanoparticles, Anthropomorphic phantoms, Computer simulations, Nanomedicine, Nanotechnology, Molecular imaging, Nuclear Medicine, radiopharmaceuticals, CRO, pharmacokinetics, in vivo imaging, in vitro studies, pharmaceuticals, bioimaging.
- HQ
- Gerakas, Attica
Bioemtech Questions
Bioemtech's website is bioemtech.com
Bioemtech's LinkedIn profile is https://gr.linkedin.com/company/bioemtech
Bioemtech has
43 employees.
View email and phone details for 43
employees at Bioemtech.
Bioemtech's industry is
Biotechnology Research
Bioemtech's top competitors are
Biocos,
Genepharm Sa,
Biomedcode,
Genekor Medical S.a.,
Elpen Pharmaceutical Co. Inc.,
Prognosis Biotech,
Hellenic Biocluster (Hbio),
Protavio Ltd,
Pharmathen,
Demo Pharmaceuticals S.a..
Bioemtech's categories are Biotechnology Research
Bioemtech's founding year is 2013
